Amniotic Membrane in Extravsatio
Not Applicable
Recruiting
- Conditions
- Extravasation Leak.Extravasation of other vesicant agent, initial encounterT80.818A
- Registration Number
- IRCT20191024045229N2
- Lead Sponsor
- Research deputy of Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 4
Inclusion Criteria
Infant with diagnosis of wound due to drug leak
Exclusion Criteria
Wound with stage 1 or 2
Congenital skin disorders
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time to epithelization. Timepoint: Before intervention and weekly until epithelization. Method of measurement: Logging the time (day).
- Secondary Outcome Measures
Name Time Method Scar Forming after Wound Treatment. Timepoint: After Wound Healing. Method of measurement: 'Vancouver Scare Scale' questionnaire.;Hospitalization Period. Timepoint: During the Study until epithelization. Method of measurement: Documents Assessment.;Sepsis. Timepoint: Before the initiation of intervention and then weekly. Method of measurement: Clinical assessment and blood sampling.